mrjСовременная ревматологияModern Rheumatology Journal1996-70122310-158XIMA-PRESS, LLC10.14412/1996-7012-2023-2-65-71mrj-1411Research ArticleКЛИНИЧЕСКИЕ НАБЛЮДЕНИЯCLINICAL OBSERVATIONSРупус – сочетание системной красной волчанки и ревматоидного артрита как отдельный фенотип болезни (описание клинического случая)Rhupus – a combination of systemic lupus erythematosus and rheumatoid arthritis as a separate disease phenotype (a clinical case)https://orcid.org/0000-0002-4160-7218НикишинаН. Ю.NikishinaN. Yu.

Нина Юрьевна Никишина

115522, Москва, Каширское шоссе, 34А

Nina Yurievna Nikishina

34A, Kashirskoe Shosse, Moscow 115522

lashinanina@gmail.comhttps://orcid.org/0000-0002-1663-7810АсееваЕ. А.AseevaE. A.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0001-5411-7317МеснянкинаА. А.MesnyankinaA. A.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

https://orcid.org/0000-0002-5206-1732СоловьевС. К.SolovievS. K.

115522, Москва, Каширское шоссе, 34А

34A, Kashirskoe Shosse, Moscow 115522

ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»РоссияV.A. Nasonova Research Institute of RheumatologyRussian Federation2023220420231726571Copyright © Никишина Н.Ю., Асеева Е.А., Меснянкина А.А., Соловьев С.К., 20232023Никишина Н.Ю., Асеева Е.А., Меснянкина А.А., Соловьев С.К.Nikishina N.Y., Aseeva E.A., Mesnyankina A.A., Soloviev S.K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://mrj.ima-press.net/mrj/article/view/1411

Рупус (Rhupus) – редкое сочетание системной красной волчанки (СКВ) и ревматоидного артрита, одной из характерных особенностей которого является развитие эрозивного полиартрита на фоне основных иммунологических признаков СКВ. В статье представлено клиническое наблюдение, в котором у пациентки наряду с типичной иммунологической картиной СКВ выявлен эрозивный полиартрит с деформациями суставов кистей по типу «шеи лебедя», что потребовало назначение анти-Вклеточной терапии.

Rhupus is a rare combination of systemic lupus erythematosus (SLE) and rheumatoid arthritis, one of the characteristic features of which is the development of erosive polyarthritis on the background of the main immunological signs of SLE. The article presents a clinical observation in which, along with the typical immunological picture of SLE, the patient was diagnosed with erosive polyarthritis with “swan neck” type deformities of the hand joints, which required administration of anti-B-cell therapy.

рупуссистемная красная волчанкаревматоидный артритритуксимабrhupussystemic lupus erythematosusrheumatoid arthritisrituximabReferencesLockshin MD, Levine AB, Erkan D. Patients with overlap autoimmune disease differ from those with 'pure' disease. Lupus Sci Med. 2015 May 6;2(1):e000084. doi: 10.1136/lupus2015-000084. eCollection 2015.Lockshin MD, Levine AB, Erkan D. Patients with overlap autoimmune disease differ from those with 'pure' disease. Lupus Sci Med. 2015 May 6;2(1):e000084. doi: 10.1136/lupus2015-000084. eCollection 2015.Suzuki K, Sawada T, Murakami A, et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol. 2003;32(4):197-204. doi: 10.1080/03009740310003677.Suzuki K, Sawada T, Murakami A, et al. High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol. 2003;32(4):197-204. doi: 10.1080/03009740310003677.Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000 Jan; 43(1):155-63. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.Schellekens GA, Visser H, de Jong BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum. 2000 Jan; 43(1):155-63. doi: 10.1002/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3.Vannini A, Cheung K, Fusconi M, et al. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis. 2007 Apr;66(4):511-6. doi: 10.1136/ard.2006. 058933. Epub 2006 Sep 19.Vannini A, Cheung K, Fusconi M, et al. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Ann Rheum Dis. 2007 Apr;66(4):511-6. doi: 10.1136/ard.2006. 058933. Epub 2006 Sep 19.Friedberg CK, Gross L, Kaufman W. Nonbacterial thrombotic endocarditis: associated with prolonged fever, arthritis, inflammation of serous membranes and widespread vascular lesions. Arch Intern Med (Chic). 1936;58(4): 662-84. doi:10.1001/archinte.1936.00170140087006Friedberg CK, Gross L, Kaufman W. Nonbacterial thrombotic endocarditis: associated with prolonged fever, arthritis, inflammation of serous membranes and widespread vascular lesions. Arch Intern Med (Chic). 1936;58(4): 662-84. doi:10.1001/archinte.1936.00170140087006Daugherty GW, Baggenstoss AH. Syndrome characterized by glomerulonephritis and arthritis Libman-Sacks disease with predominantly renal involvement. Arch Intern Med (Chic). 1950 Jun;85(6):900-23. doi: 10.1001/archinte.1950.00230120009002.Daugherty GW, Baggenstoss AH. Syndrome characterized by glomerulonephritis and arthritis Libman-Sacks disease with predominantly renal involvement. Arch Intern Med (Chic). 1950 Jun;85(6):900-23. doi: 10.1001/archinte.1950.00230120009002.Fernandez A, Quintana G, Matteson EL, et al. Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol. 2004 Dec;23(6):523-6. doi: 10.1007/s10067-004-0951-2.Fernandez A, Quintana G, Matteson EL, et al. Lupus arthropathy: historical evolution from deforming arthritis to rhupus. Clin Rheumatol. 2004 Dec;23(6):523-6. doi: 10.1007/s10067-004-0951-2.Toone EC, Irby R, Pierce EL. The L.E. cell in rheumatoid arthritis. Am J Med Sci. 1960 Nov;240:599-608.Toone EC, Irby R, Pierce EL. The L.E. cell in rheumatoid arthritis. Am J Med Sci. 1960 Nov;240:599-608.Tani C, D’Aniello A, Sedie D, et al. Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2013 Feb;12(4):537-41. doi: 10.1016/j.autrev.2012.09.004. Epub 2012 Oct 11.Tani C, D’Aniello A, Sedie D, et al. Rhupus syndrome: Assessment of its prevalence and its clinical and instrumental characteristics in a prospective cohort of 103 SLE patients. Autoimmun Rev. 2013 Feb;12(4):537-41. doi: 10.1016/j.autrev.2012.09.004. Epub 2012 Oct 11.Li J, Wu H, Huang X, et al. Clinical analysis of 56 patients with rhupus syndrome. Medicine (Baltimore). 2014 Aug;93(10):e49. doi: 10.1097/MD.0000000000000049.Li J, Wu H, Huang X, et al. Clinical analysis of 56 patients with rhupus syndrome. Medicine (Baltimore). 2014 Aug;93(10):e49. doi: 10.1097/MD.0000000000000049.Antonini L, Le Mauff B, Marcelli C, et al. Rhupus: A systematic literature review. Autoimmun Rev. 2020 Sep;19(9):102612. doi: 10.1016/j.autrev.2020.102612. Epub 2020 Jul 12.Antonini L, Le Mauff B, Marcelli C, et al. Rhupus: A systematic literature review. Autoimmun Rev. 2020 Sep;19(9):102612. doi: 10.1016/j.autrev.2020.102612. Epub 2020 Jul 12.Liu T, Li G, Mu R, et al. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus. 2014 Aug;23(9):958-63. doi: 10.1177/0961203314526439. Epub 2014 Mar 7.Liu T, Li G, Mu R, et al. Clinical and laboratory profiles of rhupus syndrome in a Chinese population: a single-centre study of 51 patients. Lupus. 2014 Aug;23(9):958-63. doi: 10.1177/0961203314526439. Epub 2014 Mar 7.Lozada-Navarro AC, Castillo-Martinez D, Moreno-Ramirez M, et al. An imbalance in the T-helper phenotypes displayed by senescent CD4(+)CD28(null) T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus. Lupus. 2018 Nov; 27(13):2155-2160. doi: 10.1177/0961203318793715. Epub 2018 Aug 15.Lozada-Navarro AC, Castillo-Martinez D, Moreno-Ramirez M, et al. An imbalance in the T-helper phenotypes displayed by senescent CD4(+)CD28(null) T cells is associated with erosive arthritis (rhupus syndrome) in systemic lupus erythematosus. Lupus. 2018 Nov; 27(13):2155-2160. doi: 10.1177/0961203318793715. Epub 2018 Aug 15.Gormezano NW, Silva CA, Aikawa NE, et al. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients. Clin Rheumatol. 2016 Jan;35(1):227-31. doi: 10.1007/s10067-0153127-3. Epub 2015 Nov 28.Gormezano NW, Silva CA, Aikawa NE, et al. Chronic arthritis in systemic lupus erythematosus: distinct features in 336 paediatric and 1830 adult patients. Clin Rheumatol. 2016 Jan;35(1):227-31. doi: 10.1007/s10067-0153127-3. Epub 2015 Nov 28.Kondo H, Watanabe R, Okazaki S, et al. Coexistence of rheumatoid arthritis and systemic lupus erythematosus is still rare in the biologic era: report of seven cases and literature review. Mod Rheumatol. 2020 Nov;30(6): 1082-3. doi: 10.1080/14397595.2019.1682795. Epub 2019 Oct 30.Kondo H, Watanabe R, Okazaki S, et al. Coexistence of rheumatoid arthritis and systemic lupus erythematosus is still rare in the biologic era: report of seven cases and literature review. Mod Rheumatol. 2020 Nov;30(6): 1082-3. doi: 10.1080/14397595.2019.1682795. Epub 2019 Oct 30.Yang BB, Xiao H, Li XJ, Zheng M. Safety and efficacy of etanercept-methotrexate combination therapy in patients with rhupus: an observational study of nonglucocorticoid treatment for rheumatic diseases. Discov Med. 2018 Jan;25(135):14-20.Yang BB, Xiao H, Li XJ, Zheng M. Safety and efficacy of etanercept-methotrexate combination therapy in patients with rhupus: an observational study of nonglucocorticoid treatment for rheumatic diseases. Discov Med. 2018 Jan;25(135):14-20.Danion F, Sparsa L, Arnaud L, et al. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients. RMD Open. 2017 Dec 29;3(2):e000555. doi: 10.1136/rmdopen-2017-000555. eCollection 2017.Danion F, Sparsa L, Arnaud L, et al. Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients. RMD Open. 2017 Dec 29;3(2):e000555. doi: 10.1136/rmdopen-2017-000555. eCollection 2017.Andrade-Ortega L, Irazoque-Palazuelos F, Munoz-Lopez S, Rosales-Don Pablo VM. Efficacy and tolerability of rituximab in patients with rhupus. Reumatol Clin. 2013 Jul-Aug; 9(4):201-5. doi: 10.1016/j.reuma.2012.10.010. Epub 2013 Feb 15.Andrade-Ortega L, Irazoque-Palazuelos F, Munoz-Lopez S, Rosales-Don Pablo VM. Efficacy and tolerability of rituximab in patients with rhupus. Reumatol Clin. 2013 Jul-Aug; 9(4):201-5. doi: 10.1016/j.reuma.2012.10.010. Epub 2013 Feb 15.Ikeda K, Sanayama Y, Makita S, et al. Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:697525. doi: 10.1155/2013/697525. Epub 2013 Nov 14.Ikeda K, Sanayama Y, Makita S, et al. Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus. Clin Dev Immunol. 2013;2013:697525. doi: 10.1155/2013/697525. Epub 2013 Nov 14.Piga M, Gabba A, Cauli A, et al. Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus. 2013 May;22(6):624-8. doi: 10.1177/0961203313482741. Epub 2013 Apr 4.Piga M, Gabba A, Cauli A, et al. Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study. Lupus. 2013 May;22(6):624-8. doi: 10.1177/0961203313482741. Epub 2013 Apr 4.Malaise O, Halleux S, von Frenckell C, et al. Rhupus: when rheumatoid arthritis meets lupus. Rev Med Liege. 2012 Sep;67(9): 475-84.Malaise O, Halleux S, von Frenckell C, et al. Rhupus: when rheumatoid arthritis meets lupus. Rev Med Liege. 2012 Sep;67(9): 475-84.Benavente EP, Paira SO. Rhupus: report of 4 cases. Reumatol Clin. 2011 Sep-Oct;7(5): 333-5. doi: 10.1016/j.reuma.2010.12.006. Epub 2011 Mar 21.Benavente EP, Paira SO. Rhupus: report of 4 cases. Reumatol Clin. 2011 Sep-Oct;7(5): 333-5. doi: 10.1016/j.reuma.2010.12.006. Epub 2011 Mar 21.Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.Chan MT, Owen P, Dunphy J, et al. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus. J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.Martinez JB, Valero JS, Bautista AJ, et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):47-53.Martinez JB, Valero JS, Bautista AJ, et al. Erosive arthropathy: clinical variance in lupus erythematosus and association with anti-CCP case series and review of the literature. Clin Exp Rheumatol. 2007 Jan-Feb;25(1):47-53.Fernandez A, Quintana G, Rondon F, et al. Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol. 2006 Mar;25(2): 164-7. doi: 10.1007/s10067-005-1149-y. Epub 2005 Jun 25.Fernandez A, Quintana G, Rondon F, et al. Lupus arthropathy: a case series of patients with rhupus. Clin Rheumatol. 2006 Mar;25(2): 164-7. doi: 10.1007/s10067-005-1149-y. Epub 2005 Jun 25.Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against cyclic citrullinated peptides in patients with "rhupus": a cross-sectional study. Arthritis Res Ther. 2006;8(5):R144. doi: 10.1186/ar2036.Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against cyclic citrullinated peptides in patients with "rhupus": a cross-sectional study. Arthritis Res Ther. 2006;8(5):R144. doi: 10.1186/ar2036.Rodriguez-Reyna TS, Alarcon-Segovia D. Overlap syndromes in the context of shared autoimmunity. Autoimmunity. 2005 May;38(3): 219-23. doi: 10.1080/08916930500050145.Rodriguez-Reyna TS, Alarcon-Segovia D. Overlap syndromes in the context of shared autoimmunity. Autoimmunity. 2005 May;38(3): 219-23. doi: 10.1080/08916930500050145.Simуn JA, Granados J, Cabiedes J, et al. Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus. 2002;11(5):287-92. doi: 10.1191/0961203302lu189oa.Simуn JA, Granados J, Cabiedes J, et al. Clinical and immunogenetic characterization of Mexican patients with 'rhupus'. Lupus. 2002;11(5):287-92. doi: 10.1191/0961203302lu189oa.Brand CA, Rowley MJ, Tait BD, et al. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis. 1992 Feb;51(2):173-6. doi: 10.1136/ard.51.2.173.Brand CA, Rowley MJ, Tait BD, et al. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features. Ann Rheum Dis. 1992 Feb;51(2):173-6. doi: 10.1136/ard.51.2.173.Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis. 1987 Nov;46(11):853-8. doi: 10.1136/ard.46.11.853.Cohen MG, Webb J. Concurrence of rheumatoid arthritis and systemic lupus erythematosus: report of 11 cases. Ann Rheum Dis. 1987 Nov;46(11):853-8. doi: 10.1136/ard.46.11.853.Pipili C, Sfritzeri A, Cholongitas E. Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med. 2008 Nov;19(7): 482-7. doi: 10.1016/j.ejim.2008.01.017. Epub 2008 Apr 1.Pipili C, Sfritzeri A, Cholongitas E. Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med. 2008 Nov;19(7): 482-7. doi: 10.1016/j.ejim.2008.01.017. Epub 2008 Apr 1.Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017 Aug; 47(1):53-64. doi: 10.1016/j.semarthrit.2017.03.022. Epub 2017 Apr 4.Ceccarelli F, Perricone C, Cipriano E, et al. Joint involvement in systemic lupus erythematosus: from pathogenesis to clinical assessment. Semin Arthritis Rheum. 2017 Aug; 47(1):53-64. doi: 10.1016/j.semarthrit.2017.03.022. Epub 2017 Apr 4.Seo SR, Lee SJ, Park DJ, et al. Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):708-11. Epub 2011 Sep 1.Seo SR, Lee SJ, Park DJ, et al. Successful treatment using cyclosporine in a patient with rhupus complicated by aplastic anemia: a case report and review of the literature. Clin Exp Rheumatol. 2011 Jul-Aug;29(4):708-11. Epub 2011 Sep 1.Zaman S, Rahim MA, Sayami LA, et al. Libman-sacks endocarditis in a bangladeshi patient suffering from rhupus. Trop Doct. 2019 Oct;49(4):309-11. doi: 10.1177/0049475519854623. Epub 2019 Jun 10.Zaman S, Rahim MA, Sayami LA, et al. Libman-sacks endocarditis in a bangladeshi patient suffering from rhupus. Trop Doct. 2019 Oct;49(4):309-11. doi: 10.1177/0049475519854623. Epub 2019 Jun 10.Piga M, Saba L, Gabba A, et al. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography. Arthritis Res Ther. 2016 Oct 4;18(1): 222. doi: 10.1186/s13075-016-1125-8.Piga M, Saba L, Gabba A, et al. Ultrasonographic assessment of bone erosions in the different subtypes of systemic lupus erythematosus arthritis: comparison with computed tomography. Arthritis Res Ther. 2016 Oct 4;18(1): 222. doi: 10.1186/s13075-016-1125-8.Zengin O, Onder ME, Sarica MA, et al. Systemic vasculitis in a patient with rhupus syndrome. Reumatismo. 2015 Dec 23;67(4): 161-4. doi: 10.4081/reumatismo.2015.858.Zengin O, Onder ME, Sarica MA, et al. Systemic vasculitis in a patient with rhupus syndrome. Reumatismo. 2015 Dec 23;67(4): 161-4. doi: 10.4081/reumatismo.2015.858.Turkcapar N, Olmez U, Ozer D, et al. A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjögren's syndrome. Rheumatol Int. 2006 Jul;26(9):841-5. doi: 10.1007/s00296-005-0084-1. Epub 2005 Nov 22.Turkcapar N, Olmez U, Ozer D, et al. A case of overlap syndrome with rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis and secondary Sjögren's syndrome. Rheumatol Int. 2006 Jul;26(9):841-5. doi: 10.1007/s00296-005-0084-1. Epub 2005 Nov 22.Kim MY, Park S, Suh CH, et al. Patient with systemic lupus erythematosus combined with erosive arthritis was treated successfully with tocilizumab: a case report. J Rheum Dis. 2018;25(2):144-147. doi: 10.4078/jrd.2018. 25.2.144.Kim MY, Park S, Suh CH, et al. Patient with systemic lupus erythematosus combined with erosive arthritis was treated successfully with tocilizumab: a case report. J Rheum Dis. 2018;25(2):144-147. doi: 10.4078/jrd.2018. 25.2.144.Dayer PVC, Rivas NL, Ferrin JJM, et al. Belimumab treatment in rhupus: a case report with severe skin involvement. Dermatol Ther. 2019 Sep;32(5):e13056. doi: 10.1111/dth.13056. Epub 2019 Aug 20.Dayer PVC, Rivas NL, Ferrin JJM, et al. Belimumab treatment in rhupus: a case report with severe skin involvement. Dermatol Ther. 2019 Sep;32(5):e13056. doi: 10.1111/dth.13056. Epub 2019 Aug 20.Kleinmann JF, Tubach F, Le Guern V, et al. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun;16(6):650-7. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.Kleinmann JF, Tubach F, Le Guern V, et al. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun;16(6):650-7. doi: 10.1016/j.autrev.2017.04.011. Epub 2017 Apr 18.Merrill JT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233.Merrill JT, Neuwelt CM, Wallace DJ, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial. Arthritis Rheum. 2010 Jan;62(1):222-33. doi: 10.1002/art.27233.Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9.Rovin BH, Furie R, Latinis K, et al. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Arthritis Rheum. 2012 Apr;64(4):1215-26. doi: 10.1002/art.34359. Epub 2012 Jan 9.McCarthy EM, Sutton E, Nesbit S, et al. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology (Oxford). 2018 Mar 1;57(3):470-9. doi: 10.1093/rheumatology/kex395.McCarthy EM, Sutton E, Nesbit S, et al. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register. Rheumatology (Oxford). 2018 Mar 1;57(3):470-9. doi: 10.1093/rheumatology/kex395.Terrier B, Amoura Z, Ravaud P, et al. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum. 2010 Aug;62(8): 2458-66. doi: 10.1002/art.27541.Terrier B, Amoura Z, Ravaud P, et al. Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry. Arthritis Rheum. 2010 Aug;62(8): 2458-66. doi: 10.1002/art.27541.Iaccarino L, Gatto M, Bettio S, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013 Jan;12(3):363-73. doi: 10.1016/j.autrev.2012.06.004. Epub 2012 Jun 26.Iaccarino L, Gatto M, Bettio S, et al. Overlap connective tissue disease syndromes. Autoimmun Rev. 2013 Jan;12(3):363-73. doi: 10.1016/j.autrev.2012.06.004. Epub 2012 Jun 26.

The authors declare that there are no conflicts of interest present.